BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 3, 2018
View Archived Issues
Prestige Biopharma recruiting healthy males subjects in PK equivalency study
Read More
Keeping trash disposal working protects mice from asthma
Read More
RBM-007 could be a treatment for achondroplasia
Read More
Immunotherapy with T cells targeting claudin 18.2 are effective and safe in gastric cancer
Read More
Long noncoding RNA LNMAT1 promotes bladder cancer metastasis
Read More
FABP4 seen to regulate ovarian cancer metastasis
Read More
Quinoline-based tracers targeting FAP show theranostic potential
Read More
Collaboration to evaluate preclinical safety and feasibility of InVivo's Neuro-Spinal Scaffold with
Read More
First clinical data presented for nifedipine in patients with hyperinsulinemic hypoglycemia
Read More
Phase III studies of Lilly's Ultra Rapid Lispro in diabetes meet primary efficacy endpoint
Read More
Clementia begins phase I trial with palovarotene eye drop formulation
Read More
Cellectar updates OS data from phase Ib trial of CLR-131 in relapsed or refractory multiple myeloma
Read More
FDA approves Seysara for acne
Read More
Antisense spherical nucleic acids proven useful for treating IBD in mice
Read More
Phase III IMPLANT 2 results show nolasiban improves live birth rate in women undergoing IVF
Read More
FDA approves Nuzyra for CABP and ABSSSI
Read More
Phase IIb study of VBP-926 in chemotherapy-associated paronychia meets primary endpoint
Read More
Sobi reports phase II primary efficacy results for anakinra in acute gout
Read More
Medshine Discovery and Fujian Cosunter Pharmaceutical patent compounds for HBV
Read More
SIMM synthesizes new PRMT5 inhibitors
Read More
Truly Translational Sweden identifies new sulfasalazine prodrugs
Read More
Palobiofarma presents adenosine A1 receptor antagonists
Read More
Bionomics' phase II trial of BNC-210 in PTSD does not meet primary endpoint
Read More
Takeda Pharmaceutical patents orexin OX2 receptor agonists
Read More